Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Nanoparticles offer hope for common skin allergy

04.04.2011
In the April 3 online issue of Nature Nanotechnology, the team will report a new approach to preventing the common skin allergy

Tiny particles only billionths of a meter in diameter—about two thousand would fit across the width of a human hair—could offer big hope in a small package to the many millions of people who are allergic to the nickel in everything from jewelry to coins and cell phones, say scientists at Brigham and Women's Hospital (BWH).

In the April 3 online issue of Nature Nanotechnology, the team will report a new approach to preventing the common skin allergy.

Approximately ten to fifteen percent of the US population, or over 30 to 45 million people, plus many more worldwide, are allergic to the nickel found in many everyday objects. For these people the metal causes a red, itchy rash when it comes into contact with their skin. You can see many examples through a quick google search for nickel-induced dermatitis.

However, even though some countries regulate the amount of the metal in certain products to limit exposure, there is no good solution to the problem. "There have been approaches to developing creams with agents that bind the nickel before it can penetrate the skin, but these are not effective in most patients and can even be toxic when the agents themselves penetrate the skin, as most do," says Jeffrey Karp, leader of the work and co-director of the Center for Regenerative Therapeutics at BWH. He adds, "People also sometimes coat their jewelry with nail polish to create a barrier between the skin and nickel ions, but this won't prevent all exposures, such as handling coins or wearing a watch."

Karp, who also holds appointments through Harvard Medical School, Harvard Stem Cell Institute (HSCI), and the Harvard-MIT Division of Health Sciences and Technology (HST), is himself allergic to nickel.

Now he and colleagues including R. Rox Anderson, a dermatologist at Harvard Medical School and Massachusetts General Hospital, have found that nanoparticles containing calcium could offer a safe solution to the problem. When applied to the skin in a cream, the nanoparticles efficiently capture the nickel, preventing it from making its way into the body. Further, the nanoparticles themselves were designed so that they cannot penetrate the skin. The cream with its nickel can then be easily washed off with water.

Says Anderson, "Despite barrier creams, anti-inflammatory drugs, and attempts to avoid nickel, this [metal] is still the most common cause of allergic skin reactions. Nanoparticles that bind to [the nickel] allergens but do not penetrate the skin offer a new strategy. Big hope in a small package!"

"We expect that a person could simply apply the cream just as they would hand cream," says Praveen Kumar Vemula of BWH, HMS, HSCI, and HST. Vemula is first author of the paper.

Toward a Solution

The idea for tackling the problem began when Karp, a specialist on nanoparticles, met Anderson at a dinner. Afterward, Karp sat at his computer thinking about how he could potentially work with the accomplished dermatologist to tackle medical problems. As he pondered, he looked at his hands, which were red and itchy from his nickel allergy. Could he and Anderson find a nontoxic, practical way to prevent nickel from penetrating the skin using nanoparticles?

The team began by focusing on compounds containing calcium, which are known to sequester nickel (some are used in the treatment of water). Next, they explored whether these compounds were available as nanoparticles. Karp knew that the tiny particles could potentially allow very efficient nickel capture thanks to their very high surface area.

The team limited their search to nanoparticles within a certain size range. "We wanted them to be large enough so they could not penetrate the skin, yet small enough to present a very large surface area for capturing nickel," Vemula says. (They ultimately decided on particles between 70 and 500 nanometers.) Finally, to cut the time involved in bringing a new technology to market, the team only explored nanoparticles already designated by the Food and Drug Administration as being generally recognized as safe (GRAS) for use in humans.

They found two compounds that met these criteria (calcium carbonate and calcium phosphate), added them to a common emollient to create a cream, and tested them under a variety of experimental conditions. For example, they applied the cream to samples of animal skin and to living animals, and tested it in the presence of artificial sweat (sweat is known to exacerbate the allergy, accelerating the release of nickel). Further, they conducted the tests with concentrations of nickel much higher than would be found in everyday situations.

"We were able to demonstrate that the particles could indeed capture nickel with high efficiency and prevent inflammation in nickel-sensitized animals," Karp says. Further, "we needed 11-fold less nanoparticles to get the same effect" as another common nickel-capture agent. (A significant drawback of the latter: it can penetrate the skin, and even small amounts can cause local and systemic toxicity.)

All results "suggest that nanoparticles can effectively prevent the penetration of nickel into the skin, and may therefore abrogate nickel-induced contact dermatitis," the team concluded in the Nature Nanotechnology paper.

The team has a patent on the work, which was funded by Brigham and Women's Hospital. Vemula is a recipient of an entrepreneur postdoctoral fellowship from the Ewing Marion Kauffman Foundation.

*PHOTO AND IMAGE CAPTIONS

Photo caption: Researchers at Brigham and Women's Hospital (BWH) believe nanoparticles could prevent the itchy, red rash millions suffer from because they are allergic to the nickel found in many everyday objects. Here Praveen Kumar Vemula of BWH and Jeffrey Karp, co-director of the Center for Regenerative Therapeutics at BWH, sit next to a graphic describing their team's approach. Vemula holds a small jar representative of a cream containing the nanoparticles. He points to Karp's finger as an example of where the cream could be applied; many people are exposed to nickel through jewelry like rings. Photo by Donna Coveney.

Image caption: Researchers from Brigham and Women's Hospital (BWH) believe that nanoparticles added to a cream or coated on a nickel-containing object could prevent the itchy redness associated with an allergy to the nickel found in everyday objects like rings. In this cartoon, a nanoparticle cream applied to the ring finger prevents inflammation from the nickel in a ring (brownish particles represent a thin barrier layer of nanoparticles). The forefinger, without the cream, is inflamed after exposure to the ring and its nickel. Courtesy: Praveen Kumar Vemula, Karp lab, BWH

Brigham and Women's Hospital (BWH) is a 793-bed nonprofit teaching affiliate of Harvard Medical School and a founding member of Partners HealthCare, an integrated health care delivery network. BWH is the home of the Carl J. and Ruth Shapiro Cardiovascular Center, the most advanced center of its kind. BWH is committed to excellence in patient care with expertise in virtually every specialty of medicine and surgery. The BWH medical preeminence dates back to 1832, and today that rich history in clinical care is coupled with its national leadership in quality improvement and patient safety initiatives and its dedication to educating and training the next generation of health care professionals. Through investigation and discovery conducted at its Biomedical Research Institute (BRI), BWH is an international leader in basic, clinical and translational research on human diseases, involving more than 900 physician-investigators and renowned biomedical scientists and faculty supported by more than $ 537 M in funding. BWH is also home to major landmark epidemiologic population studies, including the Nurses' and Physicians' Health Studies and the Women's Health Initiative. For more information about BWH, please visit www.brighamandwomens.org.

Holly Brown-Ayers | EurekAlert!
Further information:
http://www.brighamandwomens.org

More articles from Health and Medicine:

nachricht Correct connections are crucial
26.06.2017 | Charité - Universitätsmedizin Berlin

nachricht One gene closer to regenerative therapy for muscular disorders
01.06.2017 | Cincinnati Children's Hospital Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can we see monkeys from space? Emerging technologies to map biodiversity

An international team of scientists has proposed a new multi-disciplinary approach in which an array of new technologies will allow us to map biodiversity and the risks that wildlife is facing at the scale of whole landscapes. The findings are published in Nature Ecology and Evolution. This international research is led by the Kunming Institute of Zoology from China, University of East Anglia, University of Leicester and the Leibniz Institute for Zoo and Wildlife Research.

Using a combination of satellite and ground data, the team proposes that it is now possible to map biodiversity with an accuracy that has not been previously...

Im Focus: Climate satellite: Tracking methane with robust laser technology

Heatwaves in the Arctic, longer periods of vegetation in Europe, severe floods in West Africa – starting in 2021, scientists want to explore the emissions of the greenhouse gas methane with the German-French satellite MERLIN. This is made possible by a new robust laser system of the Fraunhofer Institute for Laser Technology ILT in Aachen, which achieves unprecedented measurement accuracy.

Methane is primarily the result of the decomposition of organic matter. The gas has a 25 times greater warming potential than carbon dioxide, but is not as...

Im Focus: How protons move through a fuel cell

Hydrogen is regarded as the energy source of the future: It is produced with solar power and can be used to generate heat and electricity in fuel cells. Empa researchers have now succeeded in decoding the movement of hydrogen ions in crystals – a key step towards more efficient energy conversion in the hydrogen industry of tomorrow.

As charge carriers, electrons and ions play the leading role in electrochemical energy storage devices and converters such as batteries and fuel cells. Proton...

Im Focus: A unique data centre for cosmological simulations

Scientists from the Excellence Cluster Universe at the Ludwig-Maximilians-Universität Munich have establised "Cosmowebportal", a unique data centre for cosmological simulations located at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences. The complete results of a series of large hydrodynamical cosmological simulations are available, with data volumes typically exceeding several hundred terabytes. Scientists worldwide can interactively explore these complex simulations via a web interface and directly access the results.

With current telescopes, scientists can observe our Universe’s galaxies and galaxy clusters and their distribution along an invisible cosmic web. From the...

Im Focus: Scientists develop molecular thermometer for contactless measurement using infrared light

Temperature measurements possible even on the smallest scale / Molecular ruby for use in material sciences, biology, and medicine

Chemists at Johannes Gutenberg University Mainz (JGU) in cooperation with researchers of the German Federal Institute for Materials Research and Testing (BAM)...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Plants are networkers

19.06.2017 | Event News

Digital Survival Training for Executives

13.06.2017 | Event News

Global Learning Council Summit 2017

13.06.2017 | Event News

 
Latest News

New 3-D model predicts best planting practices for farmers

26.06.2017 | Agricultural and Forestry Science

New research reveals impact of seismic surveys on zooplankton

26.06.2017 | Life Sciences

Correct connections are crucial

26.06.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>